Skip to main content
Semler Scientific, Inc. logo

Semler Scientific, Inc. — Investor Relations & Filings

Ticker · SMLR ISIN · US81684M1045 LEI · 549300ZHL16S29QTW485 US Professional, scientific and technical activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2026-02-11 Major Shareholding Noti…
Country US United States of America
Listing US SMLR

About Semler Scientific, Inc.

https://www.semlerscientific.com/

Semler Scientific, Inc. is a company that develops, manufactures, and markets technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Its primary focus is on products and services that support the early detection and treatment of chronic diseases. The company's flagship product is a patented, FDA-cleared system that provides a rapid, point-of-care test to aid in the diagnosis of peripheral artery disease (PAD). In addition to its healthcare technology operations, the company has adopted a corporate strategy to acquire and hold bitcoin as its primary treasury reserve asset.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G Filing
Major Shareholding Notification
2026-02-11 English
4 Filing
Director's Dealing
2026-01-16 English
S-8 POS Filing
Regulatory Filings Classification · 100% confidence The document is a Post-Effective Amendment No. 1 to multiple Form S-8 Registration Statements filed with the SEC. It relates to deregistration of unsold securities following a merger agreement. The document is a regulatory filing concerning securities registration and deregistration, not a financial report, earnings release, or other report types. It is not a report publication announcement since it contains substantive amendment information. The document fits best under Regulatory Filings (RNS) as it is a formal SEC filing about registration statements and amendments related to securities offerings.
2026-01-16 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the completion of a merger and details about a supplemental indenture related to convertible senior notes, including terms, conversion rights, and events of default. It is not a full annual or quarterly report, nor is it a transcript, proxy statement, or dividend notice. The document is a detailed announcement of a material definitive agreement and related financing terms, typical of a Current Report on Form 8-K. Therefore, the appropriate classification is Regulatory Filings (RNS), as Form 8-K filings are generally categorized under Regulatory Filings in this taxonomy.
2026-01-16 English
S-8 POS Filing
Regulatory Filings Classification · 100% confidence The document is titled 'POST-EFFECTIVE AMENDMENT NO. 1' to multiple Form S-8 Registration Statements filed with the SEC. It discusses the termination of the effectiveness of these registration statements following a merger agreement. The document is a formal SEC filing related to deregistration of securities and amendments to registration statements, not a financial report, earnings release, or management discussion. It is regulatory in nature, related to securities registration and deregistration, and does not contain financial statements or detailed financial analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2026-01-16 English
S-8 POS Filing
Regulatory Filings Classification · 95% confidence The document is titled 'POST-EFFECTIVE AMENDMENT NO. 1' to multiple Form S-8 Registration Statements filed with the SEC. It discusses the termination of the effectiveness of these registration statements following a merger agreement. The document is a formal SEC filing related to deregistration of securities and amendments to registration statements, not a financial report, earnings release, or management discussion. It is regulatory in nature, related to securities registration and deregistration, and does not contain financial statements or analysis. Therefore, it fits best under Regulatory Filings (RNS). The document length is 6242 characters, which is sufficient for a substantive regulatory filing rather than a brief announcement or certification.
2026-01-16 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.